2. Qin BD, Jiao XD , Yuan LY , et al.Immunotherapy-based regimens for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR-TKI therapy. J Immunother Cancer. 2024 Apr 16;12(4):e008818. doi...
Pilotto S, Molina-Vila MA, Karachaliou N, et al. Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity. Tr...
参考文献: 1. Gonzalo Pizarro et al. Case Report: Complete response to immunotherapy plus chemotherapy following an unusual clinical response to Afatinib and stereotactic radiosurgery in a metastatic EGFR-mutant NSCLC patient. Clinical Lung Cancer. 2020 2. Maximilian Johannes Hochmair et al. Successful...
Santarpia M, Dalia S, Meng R. Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases. Transl Lung Cancer Res. 2023 Nov 30;...
for immunotherapy. [Key words]advanced non-small cell lung cancer,epidermal growth factor receptor,immunotherapy Modem Oncology2022,30(11):2069-2073 【指示性摘要】肺癌是全球癌症相关死亡的主要原因。表皮生长因子受体是亚洲肺腺癌患者最常见的突变类 型。酪氨酸激酶抑制剂是表皮生长因子受体突变非小细胞肺癌一线...
[4]Yang L, Hao X, Hu X, Wang Z, Yang K, Mi Y, Yang Y, Xu H, Yang G, Wang Y. Superior efficacy of immunotherapy-based combinations over monotherapy for EGFR-mutant non-small cell lung cancer acquired resistance to EGFR-TKIs. Thorac Cancer. 2020 Oct 19. doi: 10.1111/1759-7714.13689...
[2] Ks A , Krv B , Bs C , et al. Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors[J]. Journal of Thoracic Oncology, 2018, 13( 12):1930-1939. [3] Thompson JA, Schneider BJ, Brahmer J, et al. Management of Im...
4.Madeddu C,Donisi C,Liscia N,Lai E,Scartozzi M,MacciòA.EGFR-mutated non-small cell lung cancer and resistance to immunotherapy:role of the tumor microenvironment.Int J Mol Sci.2022;23(12):6489. 5.Nogami N,Barlesi F,Socinski MA,et al.IMpower150 final exploratory analyses for atezoli...
Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases. Transl Lung Cancer Res. 2023 Nov 30;12(11):2330-2341. doi: 10.21037...
4.Madeddu C, Donisi C, Liscia N, Lai E, Scartozzi M, Macciò A. EGFR-mutated non-small cell lung cancer and resistance to immunotherapy: role of the tumor microenvironment.Int J Mol Sci. 2022;23(12):6489. 5.Nogami N, ...